Ensai Notes Enhancement vs. Session Assistant: Compare Inputs and Review Work
Evaluate Ensai documentation tools in TheraNest or Fusion by source information, recording, summaries, factual review, consent, and real completion time.
Direct answer
Ensai Notes Enhancement vs Session Assistant: what operators need to know
Evaluate Ensai documentation tools in TheraNest or Fusion by source information, recording, summaries, factual review, consent, and real completion time. Evaluate the actual input and output, not only the shared AI brand. Test whether meaning and uncertainty survive a polished rewrite.
20 minutes · Your payers and levels of care · No patient information needed
See the workflow: Marsa Health platform overview.
On this page: Direct answer

Ensora describes Ensai within TheraNest and Fusion, including documentation assistance and session-related functions. The evaluation should distinguish enhancement of supplied text, recording-based drafting, and summaries derived from prior records. Different inputs create different verification, consent, and information-handling questions.
Confirm the current product, plan, add-on terms, device support, and data arrangements directly. This independent guide supplies original test scenarios; it does not establish a partnership, live Marsa integration, clinical certification, or a result for every practice.
Key takeaways
The short version
- Evaluate the actual input and output, not only the shared AI brand.
- Test whether meaning and uncertainty survive a polished rewrite.
- Inspect recording consent, data destinations, retention, and alternatives.
- Include clinician verification and correction in the time comparison.
Take the template with you
Free to copy · no email required
Ensai source-to-output test worksheet
Compare fictional enhancement, session, and summary scenarios.
Mode,Fictional test,Expected preservation,Observed omission or addition,Review time,Decision Enhancement,Unknown fact retained,,,, Session drafting,Conflicting statement attribution,,,, Summary,Older plan superseded,,,,
Saves as ensai-evaluation-tests.csv
Test enhancement with a deliberately imperfect fictional draft
Provide a fictional note containing ambiguity, an explicitly unknown fact, and a clinically relevant negation. Ask whether the tool preserves meaning and uncertainty while improving organization. An attractive rewrite is a failure if it introduces an observation, intervention, or certainty that was not supplied.
The qualified clinician should be able to identify the source, inspect changes, correct the result, and follow the approved authentication process. Do not evaluate only a clean sample that already reads like a finished note.
Test session capture and drafting as a separate workflow
Review the actual recording or capture method, consent process, device behavior, participants, storage, access, and alternatives. Use fictional or approved test content. Examine what happens with interruptions, conflicting statements, unclear attribution, and a recording that ends early.
The practice needs a procedure for a person declining the tool or a technical failure. A draft generated from session capture still requires qualified review; the existence of a recording does not guarantee a complete or accurate clinical account.
Check summaries against the signed source record
A summary can help with preparation only if the reviewer understands which records and dates it represents. Test older and newer information, contradictory entries, unresolved questions, and changed plans. Ask whether the output clearly preserves temporal context and the limits of its source.
A fictional review might show that a prior plan was superseded. The summary should not present both as simultaneous current instructions. The clinician verifies the interpretation and the appropriate next step.

Test a partial recording and a changed consent decision
Use a fictional session in which capture stops before the conversation ends or an optional recording is declined. Ask how the clinician can identify what the draft actually represents, complete the record accurately, and use the approved alternative. The tool should not be assumed to know what occurred outside its source.
Inspect the consent and information-handling process without recording a real patient. A practice needs an appropriate fallback and clear authorship even when a feature works exactly as designed.
Choose from observed review work and the actual agreement
Compare drafting, checking, correcting, and authenticating time. Review factual support, omissions, usability, staff training, information handling, fees, export, and vendor changes. Ask which capabilities are included and which require a separate product or plan.
A practice can conclude that one mode fits a narrow use while another needs further evaluation. Retain that decision and its limits. Marsa's payer-work coordination is a separate administrative function; clinical documentation and treatment remain with the qualified clinical team.
Common questions
Answers before you build.
Are note enhancement and a session assistant the same workflow?
No. Compare the actual inputs, capture method, output, consent, source verification, and reviewer responsibilities rather than relying on a shared AI name.
Does an AI summary replace reviewing the record?
No. The clinician needs to understand the summary's sources, dates, omissions, and limitations and verify clinically relevant information.
Does this guide establish a Marsa–Ensora integration?
No. It is independent editorial analysis. Specific product connections, permissions, agreements, and implementation scope require separate confirmation.
Practical closeout
Use this operator checklist.
- Evaluate the actual input and output, not only the shared AI brand.
- Test whether meaning and uncertainty survive a polished rewrite.
- Inspect recording consent, data destinations, retention, and alternatives.
- Include clinician verification and correction in the time comparison.
Continue through the cluster
Verified customer case studies are added only with customer permission and supporting evidence; none is implied by these operational examples.
Sources & methodology
Trace the operational claims.
Marsa Health Editorial reviewed the primary and research sources below on November 5, 2026. We translate them into workflow controls, distinguish proposals from final rules, and flag where plan, program, state, contract, or clinical requirements vary.
- 01Ensai official product overview Ensora HealthVendor-authored product scope reviewed November 4, 2026; confirm the current agreement, product, configuration, and availability.Accessed or rechecked November 5, 2026
- 02Minimum necessary requirement HHSPrivacy guidance with defined scope and exceptions; organizations establish approved information handling.Accessed or rechecked November 5, 2026
- 03Security Rule guidance material HHSSecurity implementation background; marketing descriptions do not establish a vendor's compliance.Accessed or rechecked November 5, 2026
Organizational author. Editorial review covers source accuracy, search intent, workflow boundaries, and human-oversight requirements. This material is educational and does not provide clinical, legal, coding, or coverage advice.
No named clinical or legal expert reviewer is attributed to this version. Marsa Health does not invent reviewer credentials.
Read our editorial methodRevision history
What changed and when
November 5, 2026
Initial publication, source review, and operational editing.